A new series of synthetic curare-like compounds. 1951

J O HOPPE

UI MeSH Term Description Entries
D009125 Muscle Relaxants, Central A heterogeneous group of drugs used to produce muscle relaxation, excepting the neuromuscular blocking agents. They have their primary clinical and therapeutic uses in the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. They have been used also for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in MULTIPLE SCLEROSIS. (From Smith and Reynard, Textbook of Pharmacology, 1991, p358) Centrally Acting Muscle Relaxants,Central Muscle Relaxants,Relaxants, Central Muscle
D002317 Cardiovascular Agents Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. Cardioactive Agent,Cardioactive Drug,Cardiovascular Agent,Cardiovascular Drug,Cardioactive Agents,Cardioactive Drugs,Cardiovascular Drugs,Agent, Cardioactive,Agent, Cardiovascular,Drug, Cardioactive,Drug, Cardiovascular
D003472 Curare Plant extracts from several species, including genera STRYCHNOS and Chondodendron, which contain TETRAHYDROISOQUINOLINES that produce PARALYSIS of skeletal muscle. These extracts are toxic and must be used with the administration of artificial respiration.

Related Publications

J O HOPPE
December 1947, The Surgical clinics of North America,
J O HOPPE
July 1947, Anesthesiology,
J O HOPPE
May 1947, Anesthesiology,
J O HOPPE
June 1950, Laval medical,
J O HOPPE
January 1950, Gazeta medica portuguesa,
J O HOPPE
March 1970, Archives internationales de pharmacodynamie et de therapie,
J O HOPPE
January 1966, Farmakologiia i toksikologiia,
J O HOPPE
June 1952, Experientia,
J O HOPPE
June 1951, Anesthesie et analgesie,
Copied contents to your clipboard!